Unrecognized Tax Benefits of BIO-RAD LABORATORIES, INC. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
BIO-RAD LABORATORIES, INC. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • BIO-RAD LABORATORIES, INC. Unrecognized Tax Benefits for the quarter ending 30 Sep 2025 was $88,500,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $88,500,000 $0 0% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $89,300,000 +$2,200,000 +2.5% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $87,700,000 +$1,600,000 +1.9% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $86,700,000 +$2,000,000 +2.4% 31 Dec 2024 10-Q 29 Oct 2025 2025 Q3
Q3 2024 $88,500,000 -$3,500,000 -3.8% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $87,100,000 -$4,100,000 -4.5% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $86,100,000 -$1,100,000 -1.3% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $84,700,000 -$800,000 -0.94% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $92,000,000 +$18,100,000 +24% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $91,200,000 +$16,000,000 +21% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $87,200,000 +$12,100,000 +16% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $85,500,000 +$23,600,000 +38% 31 Dec 2022 10-K 14 Feb 2025 2024 FY
Q3 2022 $73,900,000 +$14,500,000 +24% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $75,200,000 +$22,100,000 +42% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $75,100,000 +$17,600,000 +31% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $61,900,000 +$6,100,000 +11% 31 Dec 2021 10-K 14 Feb 2025 2024 FY
Q3 2021 $59,400,000 +$5,000,000 +9.2% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $53,100,000 +$100,000 +0.19% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $57,500,000 +$5,800,000 +11% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $55,800,000 +$16,600,000 +42% 31 Dec 2020 10-K 16 Feb 2024 2023 FY
Q3 2020 $54,400,000 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $53,000,000 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $51,700,000 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $39,200,000 +$9,400,000 +32% 31 Dec 2019 10-K 17 Feb 2023 2022 FY
Q4 2018 $29,800,000 -$25,100,000 -46% 31 Dec 2018 10-K 11 Feb 2022 2021 FY
Q4 2017 $54,900,000 +$33,800,000 +160% 31 Dec 2017 10-K 16 Feb 2021 2020 FY
Q4 2016 $21,100,000 +$9,200,000 +77% 31 Dec 2016 10-K 02 Mar 2020 2019 FY
Q4 2015 $11,900,000 -$3,900,000 -25% 31 Dec 2015 10-K 01 Apr 2019 2018 FY
Q4 2014 $15,800,000 -$400,000 -2.5% 31 Dec 2014 10-K 16 Apr 2018 2017 FY
Q4 2013 $16,200,000 +$3,600,000 +29% 31 Dec 2013 10-K 01 Mar 2017 2016 FY
Q4 2012 $12,600,000 +$1,300,000 +12% 31 Dec 2012 10-K 29 Feb 2016 2015 FY
Q4 2011 $11,300,000 -$5,300,000 -32% 31 Dec 2011 10-K 02 Mar 2015 2014 FY
Q4 2010 $16,600,000 31 Dec 2010 10-K 18 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.